EquityOnSMS……. achieve your targets

Tue, Feb

02

02 Feb 2010: Equity Morninger & Calls

Posted in Equity (Nifty) by Prakash Tejwani (09276809789) on 02-02-2010 (23 views)

02 Feb 10, 08:40
DOW +118
Asian Mkt Positive
SGX 4945 +44

Nifty fut. (4899.45)
Supp: 4910-4880
Resi: 4960-4985

02 Feb 10, 10:45
Buy Mini Nifty Fut. 4897 SL 4874; add more above 4912

02 Feb 10, 12:15
Mini Nifty Fut. SL 4874 triggered – given @ 4897 to buy (Loss Rs 460/Lot)

Share and Enjoy:

• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 

(0) Comments

Post a comment

You must be logged in to post a comment.

• ‘Prevention is better than non-curable (your future child)’

  Catch it, before it catches your future child. Do test for Thalassemia & AIDS before Marriage/Pregnancy.

• Online Support

• Subscription Options:

  
• EquityOnSMS on Facebook

• EquityOnSMS on Twitter

• Subscribe via Email

  

  Enter your email address:

  Delivered by FeedBurner

• Wisdom Words

  When you are in the hole, stop digging – What does this mean in stock market? = When you are in deep loss – stop averaging

• Popular Tags

  ABAN AXISBank BalrampurChini BHEL BhusanSteel Copper Crude DLF EKC GodrejInd Gold GSPL HDIL ICICIBank IDBI IDFC IFCI IndiaInfo Inflation JPAssociat LT McDowell NaturalGas NHPC Nickel Nifty PrajInds PSL PTC PunjLloyd RCOM RelCapital Reliance RelInfra RNRL Rolta Satyam Silver Suzlon TataMotors TataSteel UniPhos Unitech YesBank ZeeNews

• Archives

  Select Month September 2010 August 2010 July 2010 June 2010 May 2010 April 2010 March 2010 February 2010 January 2010 December 2009 November 2009 October 2009 September 2009 August 2009 July 2009 June 2009 May 2009 April 2009 March 2009 February 2009 January 2009

• HiStats

Disclosure: Our clients may be having positions in above mentioned recommendations. We personally, our families, relatives & friends also may have positions in above mentioned recommendations.
Disclaimer: All recommendations in this website are based on subject of Technical Analysis and do not reflect the fundamental validity of the script. Authors will not be held responsible for any losses, financial or otherwise, incurred.